Optimizing Clinical Supply For A Smoother Phase 2a To 2b Transition

In this Q&A, John Davis, Regional Manager of Clinical Supplies Management at Catalent, discusses how sponsors can successfully navigate clinical supply decisions for a multi-part Phase 2 study. Davis discusses Phase 2a, which is typically a proof-of-concept study centered around dosing, and Phase 2b, which is typically used to evaluate the safety and efficacy of the drug being trialed.